Navigation Links
Publication Addresses Misconceptions About Emergency Contraception
Date:3/27/2008

MONTVALE, N.J., March 27 /PRNewswire/ -- The approval of an emergency contraceptive with over-the-counter access for individuals aged 18 years and older provides another option for preventing unintended pregnancy. However, many patients are uninformed or misinformed about how emergency contraception works and when they may need it. Clinicians should to be able to address these questions and proactively counsel patients about their risk of pregnancy.

To address this issue, OBG Management and The Journal of Family Practice have collaborated to publish "Emergency contraception: When and how to use it," distributed as a supplement to the February 2008 issues.

This publication provides clinicians with valuable information about emergency contraception. A handout sheet for patients was included to reinforce clinical counseling efforts. The publication highlights effective strategies for collaboration between clinicians and pharmacists to promote access to emergency contraception.

Supplement co-author Joseph S. Sanfilippo, MD, MBA, remarked on the relevance of this material, in light of the recent report from the CDC that shows an increased incidence of teen pregnancy: "Emergency contraception will avert the problems intrinsic to conception in this age group. Studies show that teen education about Plan B is not associated with any increase in incidence of teen sexual activity."

OBG Management, a peer-reviewed journal distributed to 40,000 ob/gyns, and The Journal of Family Practice, a peer-reviewed journal distributed to 96,000 primary care physicians, have developed this supplement under a grant from Duramed Pharmaceuticals, Inc.

Physicians can access this supplement on http://www.obgmanagement.com and on http://www.jfponline.com. Nurse practitioners and physician assistants can find this publication at http://www.apctoday.com, an online resource for advanced practice clinicians.

OBG Management and The Journal of Family Practice are published by Dowden Health Media, a Division of Lebhar-Friedman, Inc. Dowden Health Media is a full-service healthcare communications company that specializes in high-quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine & obstetrics/gynecology.


'/>"/>
SOURCE The Journal of Family Practice; OBG Management
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
5. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
7. Research by Case Western Reserve University, VA earns cover of prestigious science publication
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
10. Industry Executives Finding Value in Shift of Scientific Publications
11. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  An international ... of Medicine and St. Boniface Hospital Albrechtsen Research ... peripheral neuropathy, an unmet health need affecting nearly ... Journal of Clinical Investigation, their results identify small ... prevent and reverse neuronal injury in animal models ...
(Date:1/17/2017)... LEXINGTON, Mass. , Jan. 17, 2017   ... clinical stage biopharmaceutical company developing innovative inhaled therapies to ... candidate for treating fungal infections in the lungs of ... Infectious Disease Product" (QIDP) by the U.S. Food & ... , which is designed to speed the development of ...
(Date:1/17/2017)... 17, 2017  Only nine percent of U.S. consumers ... while only 16 percent believe health insurance companies do, ... 36 percent of U.S. adults believe health care providers ... compared to hospitals (23%). "We are in ... Wendy Salomon , vice president of reputation management and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness firm ... today the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue ... development for over a year, the patented Pono Board is the world’s only exercise ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017 MedNet ... that supports the entire spectrum of clinical research, ... another record-breaking year for the organization in terms ... in MedNet,s eClinical products and services. The company,s ... marketplace success of iMedNet ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology market is ... 19.4% from 2016 to 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):